These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

821 related items for PubMed ID: 11499862

  • 1. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats.
    Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L.
    J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862
    [Abstract] [Full Text] [Related]

  • 2. Sequential treatment with basic fibroblast growth factor and PTH is more efficacious than treatment with PTH alone for increasing vertebral bone mass and strength in osteopenic ovariectomized rats.
    Iwaniec UT, Mosekilde L, Mitova-Caneva NG, Thomsen JS, Wronski TJ.
    Endocrinology; 2002 Jul; 143(7):2515-26. PubMed ID: 12072383
    [Abstract] [Full Text] [Related]

  • 3. Both hPTH(1-34) and bFGF increase trabecular bone mass in osteopenic rats but they have different effects on trabecular bone architecture.
    Lane NE, Yao W, Kinney JH, Modin G, Balooch M, Wronski TJ.
    J Bone Miner Res; 2003 Dec; 18(12):2105-15. PubMed ID: 14672345
    [Abstract] [Full Text] [Related]

  • 4. A comparative study of the bone-restorative efficacy of anabolic agents in aged ovariectomized rats.
    Iwaniec UT, Moore K, Rivera MF, Myers SE, Vanegas SM, Wronski TJ.
    Osteoporos Int; 2007 Mar; 18(3):351-62. PubMed ID: 17120182
    [Abstract] [Full Text] [Related]

  • 5. Skeletal effects of parathyroid hormone infusion in ovariectomized rats with or without estrogen repletion.
    Shen V, Birchman R, Wu DD, Lindsay R.
    J Bone Miner Res; 2000 Apr; 15(4):740-6. PubMed ID: 10780865
    [Abstract] [Full Text] [Related]

  • 6. Bone anabolic effects of basic fibroblast growth factor in ovariectomized rats.
    Liang H, Pun S, Wronski TJ.
    Endocrinology; 1999 Dec; 140(12):5780-8. PubMed ID: 10579344
    [Abstract] [Full Text] [Related]

  • 7. Maintaining bone mass by bisphosphonate incadronate disodium (YM175) sequential treatment after discontinuation of intermittent human parathyroid hormone (1-34) administration in ovariectomized rats.
    Takano Y, Tanizawa T, Mashiba T, Endo N, Nishida S, Takahashi HE.
    J Bone Miner Res; 1996 Feb; 11(2):169-77. PubMed ID: 8822340
    [Abstract] [Full Text] [Related]

  • 8. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats.
    Ma YF, Jee WS, Ke HZ, Lin BY, Liang XG, Li M, Yamamoto N.
    J Bone Miner Res; 1995 Mar; 10(3):496-505. PubMed ID: 7785472
    [Abstract] [Full Text] [Related]

  • 9. Maintenance of increased bone mass after recombinant human parathyroid hormone (1-84) with sequential zoledronate treatment in ovariectomized rats.
    Rhee Y, Won YY, Baek MH, Lim SK.
    J Bone Miner Res; 2004 Jun; 19(6):931-7. PubMed ID: 15125792
    [Abstract] [Full Text] [Related]

  • 10. Sequential treatment of ovariectomized mice with bFGF and risedronate restored trabecular bone microarchitecture and mineralization.
    Yao W, Balooch G, Balooch M, Jiang Y, Nalla RK, Kinney J, Wronski TJ, Lane NE.
    Bone; 2006 Sep; 39(3):460-9. PubMed ID: 16713415
    [Abstract] [Full Text] [Related]

  • 11. Bone-selective analogs of human PTH(1-34) increase bone formation in an ovariectomized rat model.
    Lane NE, Kimmel DB, Nilsson MH, Cohen FE, Newton S, Nissenson RA, Strewler GJ.
    J Bone Miner Res; 1996 May; 11(5):614-25. PubMed ID: 9157776
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats.
    Wronski TJ, Yen CF, Qi H, Dann LM.
    Endocrinology; 1993 Feb; 132(2):823-31. PubMed ID: 8425497
    [Abstract] [Full Text] [Related]

  • 13. The effect of recombinant human (1-84) or synthetic human (1-34) parathyroid hormone on the skeleton of adult osteopenic ovariectomized rats.
    Kimmel DB, Bozzato RP, Kronis KA, Coble T, Sindrey D, Kwong P, Recker RR.
    Endocrinology; 1993 Apr; 132(4):1577-84. PubMed ID: 8462456
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Daily treatment of aged ovariectomized rats with human parathyroid hormone (1-84) for 12 months reverses bone loss and enhances trabecular and cortical bone strength.
    Fox J, Miller MA, Newman MK, Metcalfe AF, Turner CH, Recker RR, Smith SY.
    Calcif Tissue Int; 2006 Oct; 79(4):262-72. PubMed ID: 16969596
    [Abstract] [Full Text] [Related]

  • 16. Bone anabolic effects of subcutaneous treatment with basic fibroblast growth factor alone and in combination with estrogen in osteopenic ovariectomized rats.
    Iwaniec UT, Magee KA, Mitova-Caneva NG, Wronski TJ.
    Bone; 2003 Sep; 33(3):380-6. PubMed ID: 13678780
    [Abstract] [Full Text] [Related]

  • 17. Intermittent treatment with human parathyroid hormone (hPTH[1-34]) increased trabecular bone volume but not connectivity in osteopenic rats.
    Lane NE, Thompson JM, Strewler GJ, Kinney JH.
    J Bone Miner Res; 1995 Oct; 10(10):1470-7. PubMed ID: 8686502
    [Abstract] [Full Text] [Related]

  • 18. Temporal expression of the anabolic action of PTH in cancellous bone of ovariectomized rats.
    Meng XW, Liang XG, Birchman R, Wu DD, Dempster DW, Lindsay R, Shen V.
    J Bone Miner Res; 1996 Apr; 11(4):421-9. PubMed ID: 8992872
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cyclical treatment of osteopenic ovariectomized adult rats with PTH(1-34) and pamidronate.
    Cheng PT, Chan C, Müller K.
    J Bone Miner Res; 1995 Jan; 10(1):119-26. PubMed ID: 7747618
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.